Sort by
Refine Your Search
-
Listed
-
Employer
- Delft University of Technology (TU Delft)
- Eindhoven University of Technology (TU/e)
- European Space Agency
- Delft University of Technology (TU Delft); Delft
- Delft University of Technology (TU Delft); yesterday published
- Radboud University
- University of Amsterdam (UvA)
- University of Amsterdam (UvA); yesterday published
- Wageningen University & Research
- Amsterdam UMC
- Amsterdam UMC; Amsterdam
- Amsterdam UMC; 27 Sep ’25 published
- Amsterdam UMC; today published
- Delft University of Technology (TU Delft); 26 Sep ’25 published
- Eindhoven University of Technology (TU/e); Eindhoven
- Eindhoven University of Technology (TU/e); yesterday published
- Erasmus MC (University Medical Center Rotterdam)
- Erasmus MC (University Medical Center Rotterdam); today published
- Leiden University Medical Center (LUMC)
- Maastricht University (UM)
- Maastricht University (UM); yesterday published
- University of Amsterdam (UvA); 26 Sep ’25 published
- University of Twente
- University of Twente (UT); today published
- Wageningen University and Research Center
- 15 more »
- « less
-
Field
-
of induced pluripotent stem cells (iPSC) of PD(D)/DLB patients to identify molecular profiles and drug targets. We will collect skin biopsies from PD patients of whom brain pathological confirmation is
-
/hybrid implementations of AI algorithms, novel quantum computing algorithms, etc.); conduct theoretical studies to identify target EO use cases that could benefit from (hybrid) quantum computing solutions
-
to enhance understanding of OA pathology and facilitate the development of targeted therapies. This approach not only aims to improve patient outcomes but also seeks to address the urgent need for more
-
patient. Research in the department focuses on novel, individualized treatment strategies in the field of targeted agents and immunotherapy, either alone or in combination with conventional chemotherapy
-
transcranial magnetic stimulation (TMS) towards the development of TUS protocols for modulating subcortical targets in humans. The goal is to leverage ’lessons learned’ from TMS/TMS-EEG/fMRI research such as
-
optimization, particularly in the context of the Energy Transition. Transitioning to a power system heavily reliant on weather-dependent renewable energy to achieve environmental targets introduces a critical
-
Postdoc in Extracellular Vesicles as Mediators of Gut-Microbiome Interactions in Parkinson's Disease
disease. Using unique bacterial isolates from colonic, ileal, and fecal samples of PD patients and matched controls, you will explore EV-microbiome interactions, focusing on bacterial gene targets, growth
-
assessment processes (i.e., Constructive Alignment) when the set of learning outcomes is non-predefined. We aim to contribute a set of validated design principles and solutions for various target groups and
-
Postdoc in Extracellular Vesicles as Mediators of Gut-Microbiome Interactions in Parkinson's Disease
and matched controls, you will explore EV-microbiome interactions, focusing on bacterial gene targets, growth, virulence, and abundance. Combining EV profiling, microbial culturomics, in vitro co
-
) methods such as transcranial magnetic stimulation (TMS) towards the development of TUS protocols for modulating subcortical targets in humans. The goal is to leverage ’lessons learned’ from TMS/TMS-EEG/fMRI